Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Maternal-Fetal & Neonatal Medicine

Volume  9, Issue 2, july-december 2022, Pages 63-72
 

Review Article

Newer Approaches for Persistent Pulmonary Hypertension in Neonates: Mechanism and Treatment

Mahesh Shinde1 , Shreya Bhate2 ,Suresh Waydande3 ,Sunil Natha Mhaske4

1Junior Resident, 2Junior Resident, 3Professor and HOD, 4Professor and Dean

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijmfnm.2347.999X.9222.3

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) is a clinical syndrome of failed circulatory adaptation at birth, seen in about 2/1000 live born infants. While it is more commonly encountered in term and near term babies, it can be recognized in some premature babies with respiratory distress or bronchopulmonary dysplasia. Most commonly, PPHN is secondary to delayed or impaired relaxation of the pulmonary vasculature associated with diverse neonatal pulmonary pathologies such as meconium aspiration syndrome, congenital diaphragmatic hernia and respiratory distress syndrome.


Keywords : PPHN; Neonate; Systemic vascular resistance(SVR); Pulmonary vascular resistance(PVR); ECMO; Inhaled no; Sildenafil; Milrinone.
Corresponding Author : Shreya Bhate, Junior Resident Department of pediatric, Dr vitthalrao vikhe patil foundations medical College and hospital, Ahmednagar 414111, Maharashtra, India.shreyabhateb195@gmail.com